Latest News

Amino acid offers potential therapeutic alternative in psychiatric disorders

Improved understanding of the roles of inflammation and oxidative stress in psychiatric disorders has generated new leads in the search for novel therapies. One such investigative compound currently in clinical trials is an amino acid, N-Acetyl Cysteine (NAC), which appears to reduce the core symptoms of bipolar disorder, schizophrenia, depression, autism and cravings in addictions including cocaine, cannabis abuse and cigarette smoking.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Using cerebral protection device during transcatheter aortic valve replacement can cut number of cerebral lesions

  • Master regulator of cells' heat shock response found, pointing to new potential targets for neurodegenerative diseases and cancer

  • Researchers urge psychologists to see institutional betrayal

  • Web-based training can reduce campus rape, study concludes

  • Mobility in cancer patients with malignant spinal cord compression

  • Slowed processing speed linked with executive deficits in multiple sclerosis

  • Neural compensation in people with Alzheimer's-related protein

  • Measuring modified protein structures: New approach

  • Identifying a better message strategy for dissuading smokers: Add the positive

  • Concept of time may predict impulsive behavior, research finds

  •